Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration

Ruirui Wang, Fujing Huang, Wei Wei, Yu Zhou, Zi Ye, Liya E. Yu, Junyuan Hu, Cheguo CaiFrontiers in Cell and Developmental Biology 2021 · DOI

TL;DR

This study identifies Programmed Cell Death Ligand 1 (PD-L1) as a novel marker for mammary stem cells (MaSCs) and demonstrates its crucial role in mammary gland development and regeneration. By showing that PD-L1+ cells possess robust regenerative capabilities and that PD-L1 deficiency impairs these processes, the research opens new avenues for understanding tissue development and regenerative medicine.

What Problem Does This Paper Address?

While the role of PD-L1 in cancer immunotherapy is well-established, its physiological function in normal tissue development and regeneration has remained largely unknown. Despite PD-L1 mRNA being widely detected in various tissues, its protein expression is often restricted, leading to questions about its specific roles beyond immune modulation. This paper aims to elucidate the physiological function of PD-L1 in mammary gland development and regeneration, specifically investigating its presence and activity within mammary stem cells (MaSCs).

Methods

The researchers employed a multi-faceted approach:

  • RNA-sequencing (RNA-seq) and Quantitative Real-Time PCR (qPCR): Used to analyze PD-L1 mRNA expression levels in different mammary cell populations, particularly comparing Procr-expressing MaSCs with other basal cells.
  • Flow Cytometry: Essential for isolating and characterizing specific cell populations based on surface markers like PD-L1, CD24, and CD29. This allowed for the identification and quantification of PD-L1+ basal cells.
  • Lineage Tracing: A sophisticated technique using genetically engineered reporter mice (PD-L1CreERT2-2A-tdTomato/+; Rosa26mTmG/+) and tamoxifen induction. This allowed researchers to track the progeny of PD-L1+ cells over time, revealing their differentiation potential into various mammary epithelial cell lineages.
  • Mammary Fat Pad Transplantation Assays: A standard method to assess the regenerative capacity of isolated cells. Cells were injected into cleared mammary fat pads of recipient mice, and the ability of these cells to reconstitute a functional mammary gland was evaluated.
  • 3D Matrigel Culture (Colony Formation Assay): Used to assess the self-renewal and colony-forming potential of isolated mammary basal cells in vitro.
  • Whole-Mount and Section Imaging: Confocal microscopy was used to visualize mammary gland structures and the distribution of labeled cells. Carmine staining was employed to assess overall mammary gland morphology and development.
  • Genetic Manipulation: Creation of PD-L1 knockout (PD-L1-/-) mice and lentiviral vectors for PD-L1 overexpression were crucial for investigating the functional consequences of PD-L1 deficiency and gain-of-function.

Datasets

The study utilized data generated from experiments involving mouse models. Specifically, RNA-sequencing data from sorted mammary basal cells was analyzed. The authors also refer to publicly available datasets for Gene Set Enrichment Analysis (GSEA), with accession numbers provided in the "Data Availability Statement" (https://www.ncbi.nlm.nih.gov/, GSE166131).

Key Insights and Ideas

  • PD-L1 as a MaSC Marker: The most significant finding is the identification of PD-L1 as a marker for a subpopulation of mammary basal cells with stem cell-like properties (MaSCs). This is a novel contribution to the field of mammary gland stem cell biology.
  • PD-L1+ Cells are Highly Regenerative: These PD-L1+ basal cells demonstrated a significantly higher capacity for mammary gland regeneration in transplantation assays compared to total basal cells or PD-L1- basal cells.
  • PD-L1 Drives Mammary Development: Genetic deletion of PD-L1 led to impaired mammary gland development, particularly during puberty and early pregnancy, with delayed duct elongation and reduced alveolus formation.
  • Wnt/β-catenin Signaling Regulates PD-L1: The study revealed that PD-L1 expression in mammary basal cells is induced by the activation of the Wnt/β-catenin signaling pathway, a known regulator of mammary gland development.
  • PD-L1+ Cells are Multipotent Progenitors: Lineage tracing experiments confirmed that PD-L1+ basal cells can differentiate into all mammary epithelial lineages (basal, luminal, and alveolar cells), underscoring their multipotency.

Key Results

  • PD-L1 mRNA was found to be enriched in protein C receptor (Procr)-expressing mammary stem cells (MaSCs).
  • A small subset of adult mammary basal cells (approximately 2.05%) expressed PD-L1 on their surface.
  • PD-L1+ basal cells exhibited a 5- to 6-fold increase in colony-forming efficiency in 3D Matrigel culture compared to total basal cells.
  • In transplantation assays, PD-L1+ basal cells showed a significantly higher repopulating frequency (1/7.4) compared to total basal cells (1/64.7).
  • PD-L1-deficient mice displayed delayed mammary duct elongation and reduced TEB formation at puberty, and impaired alveolus production during early pregnancy.
  • Overexpression of PD-L1 in basal cells significantly promoted mammary regeneration capacity in transplantation assays.

Limitations and Future Work

The authors acknowledge several limitations:

  • Immune Cross-talk: While PD-L1 is a known immune regulator, its role in mediating cross-talk between mammary stem cells and immune cells (specifically T cells) was not investigated in this study.
  • Wnt/β-catenin Signaling Mechanism: The precise physiological significance of Wnt/β-catenin signaling in regulating PD-L1 transcription remains to be fully elucidated.
  • Complexity of MaSC Markers: The identification of PD-L1 adds to the growing list of MaSC markers (e.g., Procr, Bcl11b, Dll1), increasing the complexity of understanding these cell populations. The exact internal relationships and potential overlap between these markers require further investigation.

Future work could focus on exploring the immune-modulatory roles of PD-L1 in the mammary gland, further dissecting the Wnt signaling pathway's influence on PD-L1, and utilizing single-cell profiling to better understand the heterogeneity and relationships among different mammary stem cell populations. The potential application of PD-L1 in regenerative medicine is also highlighted as a promising future direction.

Summary updated

Abstract

Programmed cell death ligand 1 (PD-L1) is widely expressed in a variety of human tumors, and inhibition of the PD-L1/PD-1 pathway represents one of the most promising therapy for many types of cancer. However, the physiological function of PD-L1 in tissue development is still unclear, although <i>PD-L1</i> mRNA is abundant in many tissues. To address this puzzle, we investigated the function of PD-L1 in mammary gland development. Interestingly, we found that PD-L1 is enriched in protein C receptor (Procr)-expressing mammary stem cells (MaSCs), and PD-L1-expressing mammary basal cells (PD-L1<sup>+</sup> basal cells) exhibit robust mammary regeneration capacity in transplantation assay. The lineage tracing experiment showed that PD-L1<sup>+</sup> cells can differentiate into all lineages of mammary epithelium cells, suggesting that PD-L1<sup>+</sup> basal cells have the activities of MaSCs. Furthermore, <i>PD-L1</i> deficiency significantly impairs mammary development and reduces mammary regeneration capacity of mammary basal cells, suggesting that <i>PD-L1</i> is not only enriched in MaSCs but also improves activities of MaSCs. In summary, these results demonstrated that <i>PD-L1</i> is enriched in MaSCs and promotes mammary gland development and regeneration. Mechanistically, our data indicated that <i>PD-L1</i> expression is induced by continuous activation of Wnt/ß-catenin signaling. In conclusion, these results demonstrated that PD-L1 is a marker of MaSCs, and <i>PD-L1</i> is essential for mammary development. Our study provides novel insight into the physiological functions of PD-L1 in tissue development.
BibTeX
@inproceedings{wang2021programmed,
  author = {Ruirui Wang and Fujing Huang and Wei Wei and Yu Zhou and Zi Ye and Liya E. Yu and Junyuan Hu and Cheguo Cai},
  title = {{Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2021},
  doi = {10.3389/fcell.2021.772669},
}
Figure